Physical activity in cancer prevention
Authors:
E. Sovová; M. Sovová
Authors‘ workplace:
Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace LF UP a FN Olomouc
Published in:
Klin Onkol 2026; 39(Supplementum 1): 26-30
Category:
Review
doi:
https://doi.org/10.48095/ccko2026S26
Overview
Background: Physical activity (PA) is an important part of comprehensive prevention and treatment of cancer and has a significant impact on the quality of life of cancer patients. Current international and national recommendations support the inclusion of PA in all stages of cancer care. Aim: The aim of this paper is to summarize current knowledge about the effects of PA in cancer patients, describe the principles of its prescription, safety aspects, and possibilities for implementation into clinical practice. The text is based on a review of the professional literature and consensus recommendations focused on PA in cancer care. Regular PA has a proven positive effect on reducing fatigue, improving quality of life, cardiovascular fitness, and mental health, including reducing anxiety and depressive symptoms. For certain diagnoses, particularly breast, prostate, and colorectal cancer, PA has also been shown to reduce overall and cancer-specific mortality. The prescription of PA must be individualized concerning the type of tumor, stage of disease, selected oncological therapy, and its side effects, especially cardiopulmonary, neurological, and metabolic complications. PA can be safely included in the pre-rehabilitation phase, during active treatment, and in long-term follow-up care. Conclusion: PA is an effective and safe non-pharmacological tool in the care of cancer patients. Its wider implementation in clinical practice is limited mainly by organizational factors and low patient adherence, which emphasizes the need for interdisciplinary collaboration and systematic support for exercise programs.
Keywords:
Physical activity – cancer – prescription
Sources
1. Ministerstvo zdravotnictví České republiky. Národní onkologický plán ČR 2030. [online]. Dostupné z: https: //mzd.gov.cz/narodni-onkologicky-plan-cr-2030/.
2. Chen W, Cao L, Wu Z. Association between physical activity and prevalence/mortality of non-alcoholic fatty liver in different socioeconomic settings. Int J Public Health 2023; 68 : 1605031. doi: 10.3389/ijph.2023.1605031.
3. Campbell KL, Winters-Stone KM, Wiskemann J et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 2019; 51 (11): 2375–2390. doi: 10.1249/MSS.0000000000002116.
4. Rock CL, Thomson CA, Sullivan KR et al. American cancer society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin 2022; 72 (3): 230–262. doi: 10.3322/caac.21719.
5. Fong AJ, Sabiston CM, Nadler MB et al. Development of an evidence-informed recommendation guide to facilitate physical activity counseling between oncology care providers and patients in canada. Transl Behav Med 2021; 11 (4): 930–940. doi: 10.1093/tbm/ibaa127.
6. Hayes SC, Newton RU, Spence RR et al. The exercise and sports science australia position statement: exercise medicine in cancer management. J Sci Med Sport 2019; 22 (11): 1175–1199. doi: 10.1016/j.jsams.2019.05.003.
7. Herrero López B, Cardeña-Gutiérrez A, Godoy Ortiz A et al. Exercise in cancer patients: assistance levels and referral pathways – a position statement from the Spanish society of medical oncology. Clin Transl Oncol 2024; 27 (1): 108–116. doi: 10.1007/s12094-024-03546-w.
8. Kapounková K, Bazalová P, Šimonová M et al. Doporučení preskripce programu pohybové aktivity pro onkologické pacienty. [online]. Dostupné z: https: //www.linkos.cz/lekar-a-multidisciplinarni-tym/kvalita-zivota-lekar/osetrovatelska-pece-stomie/pobyb/doporuceni-preskripce-programu-pohybove-aktivity-pro-onkologicke-pacienty/.
9. Elbl L, Kala P, Kiss I e al. Klinická kardioonkologie. Praha: Grada 2025.
10. Brat K, Sova M, Homolka P et al. Multimodal prehabilitation before lung resection surgery: a multicentre randomised controlled trial. Br J Anaesth 2025; 135 (1): 188–196. doi: 10.1016/j.bja.2025.03.018.
11. Schwartz AL, Terry CM. Returning to sport: female athletes living with and beyond cancer. Int J Environ Res Public Health 2021; 18 (15). doi: 10.3390/ijerph18158151.
12. Baughman C, Norman K, Mukamal K. Adherence to American cancer society nutrition and physical activity guidelines among cancer survivors. JAMA Oncol 2024; 10 (6): 789. doi: 10.1001/jamaoncol.2024.0470.
13. Burešová I, Halámková J, Kiss I et al. Překážky a podpůrné faktory při zapojení onkologických pacientů do programů pohybové aktivity – literární přehled. Klin Onkol 2024; 37 (3): 178–183. doi: 10.48095/ccko2024178.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2026 Issue Supplementum 1
-
All articles in this issue
- Editorial
- Cancer screening programmes in the Czech Republic and their results
- Polygenic risk score and its role in cancer susceptibility
- Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
- Physical activity in cancer prevention
- Nicotine products on the market and cancer risk
- Impact of obesity on the development of malignant tumors – metabolic syndrome
- Mental health and sleep in cancer prevention – removing barriers to health
- Environmental exposure and cancer prevention in the Czech Republic
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Disruption of hormonal balance and the potential development of cancer – the impact of endocrine disruptors
- Microplastic in human body – a critical insight into current microplastic research
- Microbiome in early cancer detection – biomarker potential and limitations
- Probiotics, postbiotics, and synbiotics in the prevention of oncological diseases
- Clinical Oncology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Cancer screening programmes in the Czech Republic and their results
- Editorial